Gui-wen Yi

2015

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Gui-wen Yi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Cleland

Papers from Gui-wen Yi's perspective

Ordered by how strongly the researchers Gui-wen Yi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  2. Cardiac-resynchronization therapy for the prevention of heart-failure events. (New England Journal of Medicine)
  3. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
  4. Eplerenone in patients with systolic heart failure and mild symptoms. (New England Journal of Medicine)
  5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg… (European Heart Journal)
  6. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır)
  7. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. (European Heart Journal)
  8. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans (Nature Medicine)
  9. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. (The Lancet)
  10. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. (New England Journal of Medicine)

Their papers